Opportunistic Salpingectomy
On this page
Direct answer
Removing both fallopian tubes during pelvic surgery done for other reasons — benign hysterectomy or caesarean — in a woman who has completed childbearing cuts her lifetime risk of ovarian cancer: the practice of opportunistic salpingectomy. The rationale came from pathology: most "ovarian" high-grade serous carcinomas arise from serous tubal intraepithelial carcinoma in the fimbrial end, so removing the tubes removes the cancer's birthplace while leaving the ovaries in place and avoiding surgical menopause. Several international societies endorse the practice for average-risk women; it does not replace risk-reducing bilateral salpingo-oophorectomy in BRCA carriers.
What you must remember
- Origin story: molecular pathology traced high-grade serous carcinoma to the distal tube — STIC lesions in the fimbriae precede ovarian and peritoneal disease; "ovarian cancer" is largely a tubal cancer in disguise.
- Risk reduction: modelling and observational series support a substantial population-level reduction, commonly quoted in the range of 40–60% of ovarian cancer risk for average-risk women — not zero, because peritoneal origins remain possible.
- When offered: at hysterectomy for benign disease and at caesarean birth, in women who have completed their family and consent to the added operating time; societies such as the SGO and bodies endorsing the Ovarian Cancer Research Alliance initiative support the practice.
- What it is not: not a substitute for risk-reducing BSO in BRCA1/2 and other strong-familial carriers — those women still need ovaries removed at the recommended age (around 35–40 for BRCA1, 40–45 for BRCA2, individualised).
- The ovaries stay: preserving them avoids immediate oestrogen loss, bone and cardiovascular costs of surgical menopause — the entire point of separating tube from ovary.
- Surgical caution: retain careful haemostasis and respect the ovarian blood supply; a possible small effect on ovarian reserve in women not yet menopausal is debated and should be acknowledged when counselling before caesarean.
- Consent framing: discuss it as cancer-risk reduction, not sterilisation — the woman must understand fertility impact is confined to the tubes; in India this conversation must be explicit, documented and free of any pressure, echoing sterilisation-consent standards.
- Pathology discipline: every tube removed goes for histology in designated slices (SEE-FIM-style examination in high-risk cases) because occult STIC is the finding the operation is hunting.
The conversation before a caesarean
A 37-year-old, third caesarean, has completed her family and asks what else can be done while she is open. She has no family history, no BRCA mutation, and normal ovaries. The surgeon offers opportunistic bilateral salpingectomy: roughly 20 extra minutes, both tubes removed, ovaries left in place so she does not plunge into surgical menopause, and a meaningful cut in her lifetime ovarian cancer risk — a cancer found late in India because screening is unreliable. She consents with the language that the operation is prophylactic, not therapeutic, and that her ovaries remain. Now contrast the 34-year-old BRCA1 carrier: offering her tube-only removal would be inadequate — her strategy is risk-reducing BSO after 35 with HRT discussion, and the caesarean setting does not change that obligation. The third conversation is the 29-year-old still planning children: nothing is removed, and the topic is revisited at her last pelvic operation after family completion. The same 20-minute habit, three different answers, all decided by fertility status and genetic risk.
How the exam frames it
The exam question hides the answer inside pathology: "From where does high-grade serous ovarian carcinoma arise?" — the fimbrial end of the fallopian tube, with STIC as the precursor, is the modern expected answer and the seed of everything else. Follow-ups test what opportunistic means (done during surgery for another indication), why ovaries are spared (surgical menopause avoidance), and why it fails to help BRCA carriers fully (their strategy includes oophorectomy at a defined age). Candidates should expect a counselling-style stem: a woman at caesarean asking for "whatever prevents ovarian cancer" — the structured answer separates average-risk (tubes at family completion, including caesarean) from high-risk (BSO timed by gene and age), and names the limitations: risk reduced, not abolished, with no reliable screening test. Quoting that CA-125 and ultrasound screening do not reduce ovarian cancer mortality closes the reasoning loop examiners want.
Frequently asked questions
Where do most high-grade serous ovarian cancers originate?
In the distal fallopian tube, from serous tubal intraepithelial carcinoma (STIC) at the fimbriae, before spreading to the ovary and peritoneum.
What risk reduction does opportunistic salpingectomy offer?
Observational data and models support cutting average-risk women's ovarian cancer risk substantially, commonly quoted around 40–60%, since peritoneal origins remain possible.
Why are the ovaries left behind?
Removing ovaries causes immediate surgical menopause with bone and cardiovascular costs; tube-only removal targets the cancer origin without that price.
Does this apply to BRCA mutation carriers?
No — carriers still need risk-reducing bilateral salpingo-oophorectomy, around 35–40 years for BRCA1 and 40–45 for BRCA2, individualised with genetic counselling.
Can opportunistic salpingectomy be done at caesarean?
Yes, in women who have completed childbearing and consent explicitly — the tubes are removed with attention to preserving ovarian blood flow.